Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

ADVMADVM
8 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in ADVERUM BIOTECHNOLOGIES INC

BANK OF AMERICA CORP /DE/ previously held 0 shares of ADVM (ADVERUM BIOTECHNOLOGIES INC), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$2.3M

Total Shares Change

-165,495

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$4.60
0
2025-Q3
Decreased
3,614
-91.2%
$16,3720.0%$4.60
0
2025-Q2
Decreased
41,266
-19.4%
$88,7220.0%$2.32
0
2025-Q1
Increased
51,222
+17.6%
$223,8410.0%$4.61
18
2024-Q4
Increased
43,576
+16.3%
$203,5000.0%$4.69
18
2024-Q3
Decreased
37,482
-78.7%
$263,1240.0%$6.94
0
2024-Q2
Increased
176,099
+6.4%
$1.2M0.0%$6.86
27
2024-Q1
New
165,495
-
$2.3M0.0%$14.14
36

Other major holders of ADVM: FRANKLIN TEMPLETON INC, FMR LLC, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used